Circulating tumor DNA: Response Evaluation Criteria in Solid Tumors – can we RECIST? Focus on colorectal cancer

Interest in the measurement of circulating tumor DNA (ctDNA) in colorectal cancer (CRC) has increased during the past decade. The analysis of quantitative ctDNA changes as a general response evaluation criterion during systemic treatment is a scientific approach with high clinical potential, and res...

Descripción completa

Detalles Bibliográficos
Autores principales: Spindler, Karen-Lise Garm, Jakobsen, Anders
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Liquid Biopsy in Gastrointestinal Cancers: circulating tumor DNA (ctDNA) and circulating tumor cell (CTC)-based precision oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154995/
https://www.ncbi.nlm.nih.gov/pubmed/37152423
http://dx.doi.org/10.1177/17588359231171580

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154995/
https://www.ncbi.nlm.nih.gov/pubmed/37152423
http://dx.doi.org/10.1177/17588359231171580

Ejemplares similares